MR-Guided Transurethral US Ablation of Prostate Tissue for prostatic neoplasms

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trial registered. A trial in people is registered. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 18 Sep 2012: Trial registered, NCT01686958

The trials

NCT01686958: Safety Study of MRI-guided Transurethral Ultrasound Ablation of Prostate Tissue to Treat Localized Prostate Cancer

State
Completed
Phase
No phase
People
30 taking part
Started
13 Mar 2013
Primary completion
23 Mar 2015
Arms
MR-Guided Transurethral US Ablation
Results
Posted on the registry
  1. 18 Sep 2012: Trial registered
  2. 13 Mar 2013: Trial started
  3. 25 Oct 2018: Trial results posted
  4. 11 Jun 2019: Trial completed

How the status changed

  1. 19 Nov 2026: First set: Trial registered

About the treatment

Kind of treatment: Device.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.